Mon 2 Nov 2026 00:12:14 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

RTF Template


Landesamt Fuer Soziales Jugend Und Versorgung

UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

Human medicinal products


1. Authorisation Number

:

DE_RP_01_WDA_2026/3112-0192/261002

2. Name of Authorisation Holder

:

phi Pharma International GmbH & Co. KG

(ORG-100038309 / LOC-100060282)

3. Address(es) of Site(s)

:

Carl-Zeiss-Strasse 31, Hechtsheim, Mainz, Rhineland-Palatinate, 55129, Germany 




4. Legally registered address of Authorisation Holder

:

Carl-Zeiss-Strasse 31, Hechtsheim, Mainz, Rhineland-Palatinate, 55129

5. Scope of authorisation

:

ANNEX 1

6. Legal basis of authorisation

:

Art. 77(1) of Directive 2001/83/EC

7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

:

Confidential, Confidential

8. Signature

:


9. Date

:

2026-10-02

10. Annexes attached

:

Annex 1 Scope of wholesale distribution authorisation

Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

Annex 3 (Optional) Name(s) of responsible person(s)

Annex 4 (Optional) Date of Inspection on which authorisation was granted

Annex 5 (Optional) Additional provisions based on national requirements


ANNEX 1

SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



Name and address of the site: phi Pharma International GmbH & Co. KG

(ORG-100038309 / LOC-100060282)

, Carl-Zeiss-Strasse 31, Hechtsheim, Mainz, Rhineland-Palatinate, 55129, Germany   



Human medicinal products


1. MEDICINAL PRODUCTS

   1.1. with a Marketing Authorisation or registration in EEA country(s)

   1.2. without a Marketing Authorisation or registration in the EEA and intended for EEA market*

   1.3. without a Marketing Authorisation or registration in the EEA and intended for exportation


2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

   2.1. Procurement 

   2.2. Holding 

   2.3. Supply 

   2.4. Export 

   2.5. Other activities(s): (please specify) Activities within the scope of Sect 73 para 2, no. 2, 2a, 3, 3a AMG and Sect 73 para 3 AMG |Tätigkeiten im Rahmen des § 73 Abs. 2 Nr. 2, 2a, 3, 3a AMG und § 73 Abs. 3 AMG


3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

   3.1. Narcotic or psychotropic products** 

   3.2. Products requiring low temperature handling 

     3.2.1. Temperatures between 2 to 8 °C 

   3.3. Other products: (please specify here or make a reference to Annex 5) Medicinal products derived from blood; immunological medicinal prod. acc. to Art. 83 of 2001/83/EC | Arzneimittel aus Blut, immunologische Arzneimittel entsprechend Art. 83 der Richtlinie 2001/83/EC




Any restrictions or clarifying remarks (for all users):  Archiving is also performed in the 2th upper floor within the building Carl-Zeiss-Strasse 26, 55129 Mainz.
To 3.1.: Wholesale activities cover also the wholesale with the following products:
Cannabis Flos, standardized Cannabis Extract and finished medicinal products, which are covered by MedCanG.
---

Die Archivierung erfolgt zusätzlich in den Räumlichkeiten im 2. Obergeschoss der Carl-Zeiss-Straße 26, 55129 Mainz.
Zu Punkt 3.1.: Die Großhandelstätigkeit umfasst auch den Handel mit folgenden Produkten: Cannabis Flos, eingestellter Cannabisextrakt und Fertigarzneimittel, die unter das MedCanG fallen.



*Art. 5 of Directive 2001/83/EC, Art. 83 of Regulation (EC) 726/2004 and Art. 110 of Regulation 2019/6.

**Without prejudice to further authorisations as may be required according to national legislation.













Union Format for a Wholesale Distribution Authorisation

DE_RP_01_WDA_2026/3112-0192/261002


Page 1





Loading, please wait